Filtros de búsqueda

Lista de obras de Francesco Zaja

A B-cell receptor-related gene signature predicts response to ibrutinib treatment in mantle cell lymphoma cell lines

scientific article published on 28 February 2019

A Comparison of the Conditioning Regimens BEAM and FEAM for Autologous Hematopoietic Stem Cell Transplantation in Lymphoma: An Observational Study on 1038 Patients From Fondazione Italiana Linfomi

artículo científico publicado en 2018

A diachronic-comparative analysis for the identification of the most powerful prognostic index for localized diffuse large B-cell lymphoma.

artículo científico publicado en 2014

Acute hepatic failure as onset of progressive sclerodermatous chronic graft-versus-host disease after donor lymphocyte infusion

artículo científico publicado en 2005

Alemtuzumab (Campath-1H) and CHOP chemotherapy as first-line treatment of peripheral T-cell lymphoma: results of a GITIL (Gruppo Italiano Terapie Innovative nei Linfomi) prospective multicenter trial.

artículo científico publicado en 2007

Alternate use of thrombopoietin receptor agonists in adult primary immune thrombocytopenia patients: A retrospective collaborative survey from Italian hematology centers.

artículo científico publicado en 2017

Association between molecular lesions and specific B-cell receptor subsets in chronic lymphocytic leukemia.

artículo científico publicado en 2013

Bendamustine and rituximab combination is safe and effective as salvage regimen in Waldenström macroglobulinemia.

artículo científico publicado en 2015

Bendamustine in chronic lymphocytic leukemia: outcome according to different clinical and biological prognostic factors in the everyday clinical practice.

artículo científico publicado en 2013

Bendamustine in combination with ofatumumab in relapsed or refractory chronic lymphocytic leukemia: a GIMEMA Multicenter Phase II Trial.

artículo científico publicado en 2013

Bendamustine plus rituximab versus R-CHOP as first-line treatment for patients with indolent non-Hodgkin's lymphoma: evidence from a multicenter, retrospective study

artículo científico publicado en 2016

Bendamustine with or without rituximab for the treatment of heavily pretreated non-Hodgkin's lymphoma patients : A multicenter retrospective study on behalf of the Italian Lymphoma Foundation (FIL).

artículo científico publicado en 2012

Brentuximab vedotin in combination with extended field radiotherapy as salvage treatment for primary refractory Hodgkin lymphoma

artículo científico publicado en 2015

CD38, BCL-2, PD-1, and PD-1L expression in nodal peripheral T-cell lymphoma: Possible biomarkers for novel targeted therapies?

artículo científico publicado en 2016

CD49d is overexpressed by trisomy 12 chronic lymphocytic leukemia cells: evidence for a methylation-dependent regulation mechanism

article

CD49d prevails over the novel recurrent mutations as independent prognosticator of overall survival in chronic lymphocytic leukemia.

artículo científico publicado en 2016

Chlamydophila psittaci eradication with doxycycline as first-line targeted therapy for ocular adnexae lymphoma: final results of an international phase II trial.

scientific article published on 16 July 2012

Chromosome aberrations detected by conventional karyotyping using novel mitogens in chronic lymphocytic leukemia with "normal" FISH: correlations with clinicobiologic parameters.

artículo científico publicado en 2012

Consensus criteria for diagnosis, staging, and treatment response assessment of T-cell prolymphocytic leukemia

artículo científico publicado en 2019

Dapsone salvage therapy for adult patients with immune thrombocytopenia relapsed or refractory to steroid and rituximab.

artículo científico publicado en 2011

Decreased function of Fas and variations of the perforin gene in adult patients with primary immune thrombocytopenia.

artículo científico publicado en 2016

Detection of TP53 dysfunction in chronic lymphocytic leukemia by an in vitro functional assay based on TP53 activation by the non-genotoxic drug Nutlin-3: a proposal for clinical application.

artículo científico publicado en 2013

Diagnostic framing of IgM monoclonal gammopathy: Focus on Waldenström macroglobulinemia

scientific article published on 07 September 2018

Earlier administration of Rituximab allows higher rate of long-lasting response in adult patients with autoimmune thrombocytopenia

artículo científico publicado en 2006

Fludarabine plus alemtuzumab (FA) front-line treatment in young patients with chronic lymphocytic leukemia (CLL) and an adverse biologic profile.

artículo científico publicado en 2013

Fludarabine plus cyclophosphamide and rituximab in Waldenstrom macroglobulinemia: an effective but myelosuppressive regimen to be offered to patients with advanced disease

artículo científico publicado en 2011

Fludarabine, cyclophosphamide and lenalidomide in patients with relapsed/refractory chronic lymphocytic leukemia. A multicenter phase I-II GIMEMA trial.

artículo científico publicado en 2016

Fostamatinib for the Treatment of Adult Persistent and Chronic Immune Thrombocytopenia: Results of Two Phase 3, Randomized, Placebo-Controlled Trials.

artículo científico publicado en 2018

Functional and clinical relevance of VLA-4 (CD49d/CD29) in ibrutinib-treated chronic lymphocytic leukemia

artículo científico publicado en 2018

HSV-1 cutaneous infection in a patient with Hodgkin's lymphoma treated with brentuximab vedotin.

artículo científico publicado en 2013

High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial.

artículo científico publicado en 2009

High-dose therapy and autologous stem cell transplantation in marginal zone lymphomas: a retrospective study by the EBMT Lymphoma Working Party and FIL-GITMO

artículo científico publicado en 2018

Impact of clinical data on chest radiography sensitivity in detecting pulmonary abnormalities in immunocompromised patients with suspected pneumonia.

artículo científico publicado en 2009

Indolent B-cell lymphomas associated with HCV infection: clinical and virological features and role of antiviral therapy.

artículo científico publicado en 2012

Integration of cell of origin into the clinical CNS International Prognostic Index improves CNS relapse prediction in DLBCL

artículo científico publicado en 2019

Integration of transcriptional and mutational data simplifies the stratification of peripheral T-cell lymphoma

artículo científico publicado en 2019

Interferon-free antiviral treatment in B-cell lymphoproliferative disorders associated with hepatitis C virus infection.

artículo científico publicado en 2016

Interim Positron Emission Tomography Response-Adapted Therapy in Advanced-Stage Hodgkin Lymphoma: Final Results of the Phase II Part of the HD0801 Study.

artículo científico publicado en 2016

KRAS, NRAS, and BRAF mutations are highly enriched in trisomy 12 chronic lymphocytic leukemia and are associated with shorter treatment-free survival

artículo científico publicado en 2019

Lenalidomide maintenance in patients with relapsed diffuse large B-cell lymphoma who are not eligible for autologous stem cell transplantation: an open label, single-arm, multicentre phase 2 trial.

artículo científico publicado en 2017

Lenalidomide monotherapy in heavily pretreated patients with non-Hodgkin lymphoma: an Italian observational multicenter retrospective study in daily clinical practice.

artículo científico publicado en 2014

Low-dose rituximab in adult patients with idiopathic autoimmune hemolytic anemia: clinical efficacy and biologic studies

scientific article published on 20 January 2012

MATILDE chemotherapy regimen for primary CNS lymphoma: results at a median follow-up of 12 years

artículo científico publicado en 2014

MATILDE regimen followed by radiotherapy is an active strategy against primary CNS lymphomas

artículo científico publicado en 2006

MYC protein expression scoring and its impact on the prognosis of aggressive B-cell lymphoma patients

artículo científico publicado en 2018

Magnetic resonance imaging and67ga scan versus computed tomography in the staging and in the monitoring of mediastinal malignant lymphoma: a prospective pilot study ⬇️

artículo científico publicado el 1 de septiembre de 1996

Management of Hodgkin lymphoma in the era of brentuximab vedotin: real-world data from five European countries

artículo científico publicado en 2018

Management of immune thrombocytopenia in elderly patients

scientific article published on 29 September 2018

Management of relapsed/refractory mantle cell lymphoma: a review of current therapeutic strategies.

artículo científico

Molecular prediction of durable remission after first-line fludarabine-cyclophosphamide-rituximab in chronic lymphocytic leukemia

artículo científico publicado en 2015

Mutational status of IGHV is the most reliable prognostic marker in trisomy 12 chronic lymphocytic leukemia.

artículo científico publicado en 2017

Mutations in the 3′ untranslated region of NOTCH1 are associated with low CD20 expression levels chronic lymphocytic leukemia

scientific article published on 26 May 2017

NOTCH1 mutational status in chronic lymphocytic leukaemia: clinical relevance of subclonal mutations and mutation types.

artículo científico publicado en 2017

NOTCH1 mutations are associated with high CD49d expression in chronic lymphocytic leukemia: link between the NOTCH1 and the NF-κB pathways.

artículo científico publicado en 2017

NOTCH1 mutations associate with low CD20 level in chronic lymphocytic leukemia: evidence for a NOTCH1 mutation-driven epigenetic dysregulation.

artículo científico publicado en 2015

NOTCH1-mutated chronic lymphocytic leukemia cells are characterized by a MYC-related overexpression of nucleophosmin 1 and ribosome-associated components.

artículo científico publicado en 2017

New drugs and allogeneic hematopoietic stem cell transplantation for hematological malignancies: do they have a role in bridging, consolidating or conditioning transplantation treatment?

artículo científico publicado en 2017

No evidences for B-cell clonality by spectratyping analysis in patients with idiopathic thrombocytopenic purpura undergoing rituximab therapy

artículo científico publicado en 2008

Nongastric marginal-zone B-cell MALT lymphoma: prognostic value of disease dissemination

artículo científico publicado en 2006

Nonpegylated liposomal doxorubicin combination regimen in patients with diffuse large B-cell lymphoma and cardiac comorbidity. Results of the HEART01 phase II trial conducted by the Fondazione Italiana Linfomi.

artículo científico publicado en 2017

Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study

artículo científico publicado en 2003

Persistent CD49d engagement in circulating CLL cells: a role for blood-borne ligands?

artículo científico publicado en 2015

Pharmacokinetic Behavior of Rituximab

artículo científico publicado en 2005

Pixantrone for the treatment of adult patients with relapsed or refractory aggressive non-Hodgkin B-cell lymphomas

artículo científico publicado en 2014

Prognostic significance of delayed thrombocytopenia after allogeneic stem cell transplant.

artículo científico publicado en 2011

Recombinant Zoster Vaccine Significantly Reduces the Impact on Quality of Life Caused by Herpes Zoster in Adult Autologous Hematopoietic Stem Cell Transplant Recipients: A Randomized Placebo-Controlled Trial (ZOE-HSCT)

scientific article published on 05 August 2019

Rituximab in immune thrombocytopenia: gender, age, and response as predictors of long-term response.

artículo científico publicado en 2016

Rituximab in the treatment of immune thrombocytopenia: what is the role of this agent in 2019?

scientific article published on 24 May 2019

Rituximab maintenance compared with observation after brief first-line R-FND chemoimmunotherapy with rituximab consolidation in patients age older than 60 years with advanced follicular lymphoma: a phase III randomized study by the Fondazione Italia

artículo científico publicado en 2013

Rituximab treatment for glomerulonephritis in HCV-associated mixed cryoglobulinaemia: efficacy and safety in the absence of steroids

artículo científico publicado en 2006

Rituximab-dose-dense chemotherapy with or without high-dose chemotherapy plus autologous stem-cell transplantation in high-risk diffuse large B-cell lymphoma (DLCL04): final results of a multicentre, open-label, randomised, controlled, phase 3 study

artículo científico publicado en 2017

Rituximab-responsive CIDP

scientific article published on 01 November 2004

Role of bone marrow biopsy in staging of patients with classical Hodgkin's lymphoma undergoing positron emission tomography/computed tomography.

artículo científico publicado en 2017

Salvage chemotherapy with temozolomide in primary CNS lymphomas: preliminary results of a phase II trial.

artículo científico publicado en 2004

Second-line rituximab, lenalidomide, and bendamustine in mantle cell lymphoma: a phase II clinical trial of the Fondazione Italiana Linfomi.

artículo científico publicado en 2017

Short course of bortezomib in anemic patients with relapsed cold agglutinin disease: a phase 2 prospective GIMEMA study

artículo científico publicado en 2018

Single-agent panobinostat for relapsed/refractory diffuse large B-cell lymphoma: clinical outcome and correlation with genomic data. A phase 2 study of the Fondazione Italiana Linfomi

artículo científico publicado en 2018

Splenectomy as a curative treatment for immune thrombocytopenia: a retrospective analysis of 233 patients with a minimum follow up of 10 years.

artículo científico publicado en 2012

Successful treatment and FDG-PET/CT monitoring of HHV-6 encephalitis in a non-neutropenic patient: case report and literature review.

artículo científico publicado en 2017

Sustained response to low-dose rituximab in idiopathic autoimmune hemolytic anemia

artículo científico publicado en 2013

Targeting Mutant BRAF in Relapsed or Refractory Hairy-Cell Leukemia

artículo científico publicado en 2015

Temozolomide as salvage treatment in primary brain lymphomas.

artículo científico publicado en 2007

The SIRT1/TP53 axis is activated upon B-cell receptor triggering via miR-132 up-regulation in chronic lymphocytic leukemia cells.

artículo científico publicado en 2015

The efficacy of lenalidomide combination therapy in heavily pretreated non-Hodgkin lymphoma patients: an Italian observational, multicenter, retrospective study.

artículo científico publicado en 2016

Thrombopoietin receptor agonists for preparing adult patients with immune thrombocytopenia to splenectomy: results of a retrospective, observational GIMEMA study

artículo científico publicado en 2016

Thrombotic risk in patients with primary immune thrombocytopenia is only mildly increased and explained by personal and treatment-related risk factors.

artículo científico publicado en 2014

Treatment for patients with relapsed/refractory mantle cell lymphoma: European-based recommendations.

artículo científico publicado en 2017

Treatment of refractory chronic GVHD with rituximab: a GITMO study.

artículo científico publicado en 2007

Trisomy 8 in chronic lymphocytic leukemia: a report of two cases

artículo científico publicado en 2007

Two cases of concomitant diffuse large B-cell lymphoma and myelodysplastic syndrome

artículo científico publicado en 2014

Update on the molecular pathogenesis and targeted approaches of mantle cell lymphoma: summary of the 12th annual conference of the European Mantle Cell Lymphoma Network.

artículo científico publicado en 2014

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda